Stereotaxis, Inc. (STXS)

1.82 -0.05 (-2.57%)

As of 2026-04-02 18:51:18 EST

Stereotaxis Inc. is an American publicly traded medical technology company based in St. Louis, Missouri, that makes robotic systems used by physicians to perform minimally-invasive endovascular procedures, including electrophysiology studies and cardiac catheter ablation procedures.

Traded asNYSE: STXS
ISINUS85916J4094
CIK0001289340
LEI549300KPNOKI02O2ZP21
EIN943120386
Sector
IndustryElectromedical & Electrotherapeutic Apparatus
CEODavid L. Fischel
Employees
Fiscal Year End1231
Address710 N TUCKER BLVD, ST.LOUIS, MO, 63101
Phone314-678-6100
Websitehttps://www.stereotaxis.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
STXSStereotaxis, Inc.2026-04-02 18:51:181.82-0.05-2.57
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
STXS0001289340Stereotaxis, Inc.US85916J4094549300KPNOKI02O2ZP21943120386NYSE3845Electromedical & Electrotherapeutic Apparatus1231DE710 N TUCKER BLVDST.LOUISMO63101UNITED STATESUS314-678-6100710 N TUCKER BLVD, ST.LOUIS, MO, 63101710 N TUCKER BLVD, ST.LOUIS, MO, 63101David L. Fischelhttps://www.stereotaxis.com150,300,00095,339,62897,248,936Stereotaxis Inc. is an American publicly traded medical technology company based in St. Louis, Missouri, that makes robotic systems used by physicians to perform minimally-invasive endovascular procedures, including electrophysiology studies and cardiac catheter ablation procedures.2026-04-02 18:54:11
This is a preview of the latest data. Subscribe to access the full data.
STXS Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
STXS Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2025150,300,00026,400,00021.307597,248,93611,269,27413.1069
2024123,900,00023,000,00022.794885,979,6623,850,9004.6889
2023100,900,000-9,800,000-8.852882,128,7627,083,2789.4386
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Kimberly R. PeeryChief Financial Officer2025232,500020,00018,211326,111
David L. FischelChief Executive Officer202560,000004,39064,390
David L. FischelChief Executive Officer202460,000002,19562,195
Kimberly R. PeeryChief Financial Officer2024226,750020,0008,895340,165
David L. FischelChief Executive Officer202360,000002,19562,195
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
2025131
2024139
2023122
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue26,918,00026,771,000
Cost Of Revenue12,324,00011,911,000
Gross Profit14,594,00014,860,000
Research And Development Expenses9,760,00010,273,000
General And Administrative Expenses17,201,00014,050,000
Operating Expenses39,333,00036,699,000
Operating Income-24,739,000-21,839,000
Net Income-24,045,000-20,713,000
Earnings Per Share Basic-0.3-0.27
Earnings Per Share Diluted-0.3-0.27
Weighted Average Shares Outstanding Basic85,183,30680,702,358
Weighted Average Shares Outstanding Diluted85,183,30680,702,358
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents12,217,00019,818,000
Marketable Securities Current
Accounts Receivable3,824,0003,822,000
Inventories8,331,0008,426,000
Non Trade Receivables
Other Assets Current
Total Assets Current26,439,00033,267,000
Marketable Securities Non Current
Property Plant And Equipment3,573,0003,304,000
Other Assets Non Current
Total Assets Non Current20,285,0008,642,000
Total Assets46,724,00041,909,000
Accounts Payable5,668,0003,190,000
Deferred Revenue6,804,0006,657,000
Short Term Debt
Other Liabilities Current2,922,0002,972,000
Total Liabilities Current21,602,00013,247,000
Long Term Debt
Other Liabilities Non Current64,00043,000
Total Liabilities Non Current13,690,0006,742,000
Total Liabilities35,292,00019,989,000
Common Stock85,00081,000
Retained Earnings-561,725,000-537,680,000
Accumulated Other Comprehensive Income
Total Shareholders Equity6,080,00016,343,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization382,000595,000
Share Based Compensation Expense10,262,00010,623,000
Other Non Cash Income Expense
Change In Accounts Receivable-691,000-1,268,000
Change In Inventories-677,000550,000
Change In Non Trade Receivables
Change In Other Assets-29,000-71,000
Change In Accounts Payable758,000218,000
Change In Other Liabilities21,000-8,000
Cash From Operating Activities-8,497,000-9,139,000
Purchases Of Marketable Securities
Sales Of Marketable Securities
Acquisition Of Property Plant And Equipment34,000366,000
Acquisition Of Business
Other Investing Activities
Cash From Investing Activities74,00019,765,000
Tax Withholding For Share Based Compensation
Payments Of Dividends
Issuance Of Common Stock297,00081,000
Repurchase Of Common Stock
Issuance Of Long Term Debt
Repayment Of Long Term Debt
Other Financing Activities
Cash From Financing Activities297,00081,000
Change In Cash-8,126,00010,707,000
Cash At End Of Period12,217,00019,818,000
Income Taxes Paid
Interest Paid694,0001,096,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share-0.3-0.27
Price To Earnings Ratio-7.6-6.4815
Earnings Growth Rate11.11113.8462
Price Earnings To Growth Ratio-0.684-1.6852
Book Value Per Share0.13420.2716
Price To Book Ratio16.9896.4429
Ebitda-22,969,000-19,022,000
Enterprise Value
Dividend Yield
Dividend Payout Ratio
Debt To Equity Ratio
Capital Expenditures651,00068,000
Free Cash Flow-9,148,000-9,207,000
Return On Equity-3.9548-1.2674
One Year Beta1.33450.92830.4367
Three Year Beta1.01481.11111.1206
Five Year Beta1.15060.9620.9814
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
SHAMIR NACHUMDirector2026-01-0246,948A136,224
Levin Ross BDirector2026-01-0246,948A578,145
Fischel NathanDirector, 10% owner2026-01-0246,948A677,672
Curet MyriamDirector2026-01-0246,948A392,058
Benfer DavidDirector2026-01-0246,948A515,872
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Hickory Point Bank & Trust2026-03-312,7601,5001.84
Investors Research Corp2026-03-3133,02817,9501.84
GOLDMAN SACHS GROUP INC2025-12-31475,031206,5352.3
HSBC HOLDINGS PLC2025-12-31156,41968,6052.28
Rockefeller Capital Management L.P.2025-12-3110,9254,7502.3
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
Global X Funds2026-01-31Global X Russell 2000 ETFRSSL27,44160,095.790.0043
ProFunds2026-01-31SMALL-CAP PROFUND SERVICE CLASSSLPSX63137.970.0018
ProFunds2026-01-31SMALL-CAP PROFUND INVESTOR CLASSSLPIX63137.970.0018
ProFunds2026-01-31ULTRASMALL-CAP PROFUND SERVICE CLASSUAPSX7741,695.060.0032
ProFunds2026-01-31ULTRASMALL-CAP PROFUND INVESTOR CLASSUAPIX7741,695.060.0032
This is a preview of the latest data. Subscribe to access the full data.